School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Evid Based Complement Alternat Med. 2014;2014:528396. doi: 10.1155/2014/528396. Epub 2014 Feb 20.
Zuojin Wan (ZJW) and Lizhong Wan (LZW) have been widely used in the treatment of Stomach heat and cold syndrome (SH and SC), respectively. In this study, a proton nuclear magnetic resonance ((1)H NMR) based metabonomic approach was developed to profile SH and SC-related metabolic perturbations in rat serum and to investigate the intervention effects of ZJW and LZW on the corresponding SH and SC. Compared to the conventional macroscopic and histopathological examinations, the metabonomic approach could enable discrimination between SH and SC based on serum metabolic profiles. Meanwhile, 17 and 15 potential biomarkers associated with SH and SC, respectively, which were mainly involved in gastric dysfunction and mucosal lesions, gut microbiotal activity, transmethylation, glucose and lipid metabolism, and amino acid metabolism, were identified. Furthermore, taking the potential biomarkers as drug targets, it was revealed that administration of ZJW and LZW could exclusively reverse the pathological process of SH and SC, respectively, through partially regulating the disturbed metabolic pathways. This work showed biological basis related to SH and SC at metabolic level and offered a new paradigm for better understanding and explanation of "Fang Zheng Dui Ying" principle in traditional Chinese medicine from a systemic view.
左金丸(ZJW)和理中丸(LZW)分别被广泛用于治疗胃热证和胃寒证(SH 和 SC)。在这项研究中,建立了基于质子核磁共振(1H NMR)的代谢组学方法来描绘大鼠血清中与 SH 和 SC 相关的代谢紊乱,并研究 ZJW 和 LZW 对相应的 SH 和 SC 的干预作用。与传统的宏观和组织病理学检查相比,代谢组学方法可以根据血清代谢谱区分 SH 和 SC。同时,鉴定出与 SH 和 SC 分别相关的 17 个和 15 个潜在生物标志物,这些标志物主要涉及胃功能障碍和黏膜损伤、肠道微生物群活性、转甲基化、葡萄糖和脂质代谢以及氨基酸代谢。此外,以潜在生物标志物为药物靶点,揭示了 ZJW 和 LZW 的给药可以通过部分调节紊乱的代谢途径,分别专一地逆转 SH 和 SC 的病理过程。这项工作在代谢水平上展示了与 SH 和 SC 相关的生物学基础,并从系统的角度为更好地理解和解释中医的“方证对应”原则提供了新的范例。